ArticleCureus2026
Epidemiological, Clinicopathological, and Surgical Characteristics of Eyelid Carcinomas: A Three-Year Retrospective Case Series From Eastern Morocco.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Eyelid carcinomas are the most common malignant tumors of the periocular region and require a balance between complete oncologic resection and functional reconstruction. This study aimed to describe the demographic, clinical, and histopathological characteristics of patients with eyelid carcinoma treated surgically at a tertiary referral center in Eastern Morocco, while evaluating surgical management strategies, reconstructive approaches, postoperative complications, and short- to mid-term recurrence outcomes. Methods This retrospective study was conducted over a three-year period, from January 2023 to December 2025, and included 20 patients with eyelid carcinomas who underwent surgical treatment in the Department of Plastic and Reconstructive Surgery at Mohammed VI University Hospital, Oujda, Morocco. Demographic, clinical, histopathological, therapeutic, and outcome data were analyzed. Results Twenty patients were included, comprising 11 women (55%) and 9 men (45%), with a mean age of 63.1 years. Chronic sun exposure was identified in 18 patients (90%). The lower eyelid was the most commonly affected site in nine cases (45%). Basal cell carcinoma (BCC) accounted for 15 tumors (75%), followed by squamous cell carcinoma (SCC) in five cases (25%). Wide local excision with histopathological margin control was performed in all patients (20/20, 100%), and orbital exenteration was required in one case (5%). Reconstruction was achieved mainly using local flaps in 12 patients (60%). Ectropion occurred in two patients (10%). No local recurrence was observed during a mean follow-up of 22 months. Conclusion Eyelid carcinomas, particularly BCC, represent a significant therapeutic challenge, with surgery remaining the mainstay of treatment. The optimal management strategy relies on prevention and early diagnosis of lesions, which are essential to improve prognosis and prevent disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.